abstract |
A pharmaceutical composition adapted for oral administration comprising 10, 12, 5, 15, 20, 25, 30 or 40 mg of paroxetine methanesulfonate per unit dose, calculated on the free basis, and a pharmaceutically acceptable carrier comprising a disintegrant. |